Poland· PL-100039743
Lorinden A
A flumetasone product containing acidum salicylicum + flumetasonum, registered in Poland by Bausch Health Ireland Ltd.. The same ATC class is registered in 4 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Flumetasone is registered in 4 of 19 countries.
Countries holding a registration under ATC D07XB01 (flumetasone), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 3 of them publish a price we can compare per daily dose
Flumetasone · ATC D07XB01
4 / 19 countries
- Belgiumprice
- Finlandprice
- Netherlands
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Acidum salicylicum + Flumetasonum
- Manufacturer
- Bausch Health Ireland Ltd.
- Country
- Poland (PL)
- ATC code
- D07XB01
- ATC class
- Flumetasone
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05909990229512
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Flumetasone in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyKeratoson Comp.Infectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim
- FinlandLocasalenNovartis Finland Oy
Authorised across Europe · EMA
The same active substance is authorised in 7 EEA countries. Names it is sold under:
- Bulgaria · Лоринден A
- Germany · Keratoson Comp., Keratoson Comp. Lösung
- Hungary · Lorinden A
- Italy · Losalen
- Lithuania · Lorinden A
- Latvia · Lorinden A
- Netherlands · Locasalen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e3ec32a3-2bad-4dc9-a6f7-862311cfe4aa GET /v1/drugs/e3ec32a3-2bad-4dc9-a6f7-862311cfe4aa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Maść",
"source": "urpl",
"strength": "(30 mg + 0,2 mg)/g",
"packaging": "Rp ¦ Skasowane ¦ 6107\n1 op. 60 g\n05909990229512 ¦ Rp ¦ 44575\n1 op. 15 g",
"substance": "Acidum salicylicum 30 mg/g + Flumetasoni pivalas 0.2 mg/g",
"common_name": "Acidum salicylicum + Flumetasonum",
"pl_product_id": "100039743",
"pozwolenie_nr": "02295",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about flumetasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.